Vultaggio Vincent

Insider profile

Performance

Overall performance
1.6

Performance over holding periods
1.6
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Vultaggio Vincent's trades of Zentalis Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-10 2026-02-10 PlS Planned sale
30,346 -20.0%
125.13
US$1,141,369
30,346 -20.0% 125.13 US$1,141,369
2026-02-10 2026-02-09 S Sale
65,419 +18.6%
120.38
US$593,249
65,419 +18.6% 120.38 US$593,249
2026-02-10 2026-02-06 S Sale
27,699 -23.7%
403.99
US$1,915,349
27,699 -23.7% 403.99 US$1,915,349
2026-02-04 2026-02-03 PlS Planned sale
556 -0.3%
2.52
US$1,398
556 -0.3% 2.52 US$1,398
2026-02-04 2026-02-03 PlS Planned sale
556 -0.3%
2.52
US$1,398
556 -0.3% 2.52 US$1,398
2026-02-04 2026-02-02 S Sale
2,540 -1.3%
2.55
US$6,477
2,540 -1.3% 2.55 US$6,477
2025-02-05 2025-02-03 S Sale
2,615 -1.4%
1.71
US$4,476
2,615 -1.4% 1.71 US$4,476
2024-10-04 2024-10-04 PlS Planned sale
1,603 -4.5%
3.18
US$5,098
1,603 -4.5% 3.18 US$5,098